Covered recipient · General Payments record
JACQUELINE L KOSHOREK
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2022–2023
$1,183.06
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $825.94 | 8 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $146.95 | 2 |
| Genentech USA, Inc. | $124.98 | 1 |
| ABBVIE INC. | $123.80 | 1 |
| GENZYME CORPORATION | $116.65 | 1 |
| Biogen, Inc. | $108.87 | 1 |
| Horizon Pharma plc | $107.33 | 1 |
| Alexion Pharmaceuticals, Inc. | $97.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $123.80 | 09/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997681071 | CMS |
| Alexion Pharmaceuticals, Inc. | $97.36 | 10/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1017018339 | CMS |
| Biogen, Inc. | $108.87 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012177765 | CMS |
| Genentech USA, Inc. | $124.98 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040383513 | CMS |
| GENZYME CORPORATION | $116.65 | 08/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050255255 | CMS |
| Horizon Therapeutics plc | $107.33 | 07/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987032557 | CMS |
| Novartis Pharmaceuticals Corporation | $49.26 | 07/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 992168491 | CMS |
| NOVARTIS PHARMACEUTICALS CORPORATION | $97.69 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 993432049 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.